1. Home
  2. UVSP vs ERAS Comparison

UVSP vs ERAS Comparison

Compare UVSP & ERAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UVSP
  • ERAS
  • Stock Information
  • Founded
  • UVSP 1876
  • ERAS 2018
  • Country
  • UVSP United States
  • ERAS United States
  • Employees
  • UVSP N/A
  • ERAS N/A
  • Industry
  • UVSP Major Banks
  • ERAS Biotechnology: Pharmaceutical Preparations
  • Sector
  • UVSP Finance
  • ERAS Health Care
  • Exchange
  • UVSP Nasdaq
  • ERAS Nasdaq
  • Market Cap
  • UVSP 855.6M
  • ERAS 723.8M
  • IPO Year
  • UVSP 1989
  • ERAS 2021
  • Fundamental
  • Price
  • UVSP $29.67
  • ERAS $1.92
  • Analyst Decision
  • UVSP Hold
  • ERAS Strong Buy
  • Analyst Count
  • UVSP 2
  • ERAS 5
  • Target Price
  • UVSP $28.00
  • ERAS $5.70
  • AVG Volume (30 Days)
  • UVSP 81.7K
  • ERAS 1.5M
  • Earning Date
  • UVSP 01-22-2025
  • ERAS 11-12-2024
  • Dividend Yield
  • UVSP 2.79%
  • ERAS N/A
  • EPS Growth
  • UVSP N/A
  • ERAS N/A
  • EPS
  • UVSP 2.49
  • ERAS N/A
  • Revenue
  • UVSP $288,319,000.00
  • ERAS N/A
  • Revenue This Year
  • UVSP N/A
  • ERAS N/A
  • Revenue Next Year
  • UVSP $4.14
  • ERAS N/A
  • P/E Ratio
  • UVSP $11.93
  • ERAS N/A
  • Revenue Growth
  • UVSP N/A
  • ERAS N/A
  • 52 Week Low
  • UVSP $18.41
  • ERAS $1.64
  • 52 Week High
  • UVSP $32.75
  • ERAS $3.45
  • Technical
  • Relative Strength Index (RSI)
  • UVSP 52.88
  • ERAS 32.17
  • Support Level
  • UVSP $28.56
  • ERAS $1.77
  • Resistance Level
  • UVSP $30.45
  • ERAS $1.98
  • Average True Range (ATR)
  • UVSP 0.72
  • ERAS 0.18
  • MACD
  • UVSP 0.18
  • ERAS -0.06
  • Stochastic Oscillator
  • UVSP 85.93
  • ERAS 16.36

About UVSP Univest Financial Corporation

Univest Financial Corp is engaged in domestic banking services for individuals, businesses, municipalities and non-profit organizations. The bank has three operating segments; Banking segment provides financial services including a full range of banking services such as deposit taking, loan origination, and servicing, mortgage banking, other general banking services, and equipment lease financing, Wealth Management segment offers investment advisory, financial planning, trust and brokerage services, and The Insurance segment includes a full-service insurance brokerage agency offering commercial property and casualty insurance, employee benefits solutions, personal insurance lines and human resources consulting. It generates majority of its revenue from the banking segment.

About ERAS Erasca Inc.

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.

Share on Social Networks: